oseltamavir phosphate is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Rpk Pharmaceuticals, Inc.. The primary component is Oseltamivir Phosphate.
| Product ID | 53002-3387_4c85da2d-993e-4a4e-8dc5-d8f554b478e2 |
| NDC | 53002-3387 |
| Product Type | Human Prescription Drug |
| Proprietary Name | oseltamavir phosphate |
| Generic Name | Oseltamavir Phosphate |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2017-09-21 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA207211 |
| Labeler Name | RPK Pharmaceuticals, Inc. |
| Substance Name | OSELTAMIVIR PHOSPHATE |
| Active Ingredient Strength | 75 mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2018-10-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA207211 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2018-10-01 |
| Inactivation Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| OSELTAMIVIR PHOSPHATE | 75 mg/1 |
| SPL SET ID: | 5bb70d91-1beb-4183-902e-bdcf907be5c3 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 33342-256 | oseltamavir phosphate | oseltamavir phosphate |
| 33342-257 | oseltamavir phosphate | oseltamavir phosphate |
| 33342-258 | oseltamavir phosphate | oseltamavir phosphate |
| 53002-3387 | oseltamavir phosphate | oseltamavir phosphate |
| 68071-4739 | oseltamavir phosphate | oseltamavir phosphate |
| 68788-7106 | oseltamavir phosphate | oseltamavir phosphate |
| 70518-1727 | oseltamavir phosphate | oseltamavir phosphate |
| 71205-107 | oseltamavir phosphate | oseltamavir phosphate |
| 71205-417 | oseltamavir phosphate | oseltamavir phosphate |
| 50090-4159 | Oseltamivir phosphate | oseltamavir phosphate |